Abbvie
Samantha Neville
Field Access Specialist - Northeast
Cell:(727) 401-9924
Venclexta https://www.venclexta.com/cll/support-and-resources/financial-support.html
Adaptive Biotechnologies
Karuna Craig
Patient Access and Reimbursement Manager
kcraig@adaptivebiotech.com
Patient Hotline (855) 236 9230
Clinical Services (888) 552-8988
https://www.clonoseq.com/adaptive-assist
Agios Pharmaceuticals
Farida Ayub, Patient Support Manager
Farida.ayub@agios.com
(617) 340-3917
My Agios Patient Services
Alexion
Jen Ulven
Field Reimbursement Manager
1-904-874-3344
Jen.Ulven@Alexion.com
Ultomiris, Soliris
AMAG Pharmaceuticals
Feraheme Assist
Feraheme IV Iron
Mariaelena Galie
Senior Manager, Patient Services
267-275-1185
https://www.feraheme.com/patient-support/
Amgen
Amy Zhan
Cell 908-894-3385
Toll free: 844-889-9222 Option 3, Option 1, Extension 1
Email; amy.zhan@syneoshealth.com
Amgen Support Plus
https://www.amgensupportplus.com/
Astellas
Kevin Kobylinski
Access and Reimbursement Manager
NH/VT/ME/MA/CT/RI
C: 603-502-8175
E-mail: kevin.kobylinski@Astellas.com
PADCEV™ (enfortumab vedotin-ejfv), Xospata® (gilteritinib), Xtandi® (enzalutamide)
https://www.astellaspharmasupportsolutions.com/
AstraZeneca/MedImmune
Jenifer N. McNulty
Field Reimbursement Manager
MA, ME, NH, VT, RI
Cell 617.818.3517
jenifer.mcnulty@astrazeneca.com
Imfinzi, Tagrisso, Lynparza, Calquence, Faslodex, Imjudo, Iressa, Enhertu, Truqap
Joann Dousa, RPh, AE-C
Field Reimbursement Manager, Oncology
Connecticut, Upstate New York, Western MA
Cell: 508-813-2834
Joann.Dousa@astrazeneca.com
Imfinzi, Tagrisso, Lynparza, Calquence, Faslodex, Imjudo Iressa, Enhertu, Truqap
My Access 360 | Helping Patients Access the Care They Need
Aveo Oncology
Caroline Ward, RN, BSN
Oncology Account Manager-New England
cward@aveooncology.com
603-707-6223
Product: Fotivda (tivozanib)
AVEO ACE Program- Access Center of Excellence
www.fotivda.com to enroll
1-833-Fotivda (1-833-368-4832)
Bayer
Jerry George
Field Reimbursement Manager
Bayer Oncology
(716) 308-4143, cell
(585) 492-5261, fax
jerry.george@bayer.com
Xofigo, Nexavar, Nubeqa,Stivarga and Aliqopa
Xofigo Patient Assistance
Aliqopa Patient Assistance
Vitrakvi Patient Assistance
Nubeqa Patient Assistance
BeiGene
Jeff Wilhour
Director, Field Market Access
Cell: 410-804-2619
jeff.wilhour@beigene.com
Brukinsa Patient Support
1-833-234-4363
Patient Access: https://www.mybeigene.com/
Brukinsa
Blueprint Medicines
Fred Richards
Associate Director, Regional Marketing
New England and New York
Blueprint Medicines
Frichards@blueprintmedicines.com
Cell# 781-258-1457
Blueprint Medicines Global Headquarters
45 Sidney Street
Cambridge, MA 02139
Ayvakit (avapritinib) Indicated for: Systemic Mastocytosis (Indolent SM, Smoldering SM, Advanced SM, SM with AHN), and PDGFRA GIST
Ayvakit Product Information: https://ayvakit.com/
Ayvakit Patient Support Programs: https://yourblueprint.com/
Unbranded/Disease Awareness: https://itssmthing.com/
Gavreto (pralsetinib) – Indicated for: RET+ mNSCLC and RET+ advanced or metastatic thyroid carcinoma
Gavreto Product Information: https://www.gavreto.com/
BMS Access Support
James Blanchard
Manager, Access & Reimbursement Manager
Manchester, NH (ME, NH, VT)
Cell (207) 232-3395
james.blanchard@bms.com
www.BMSAccessSupport.com
Oncology
Abraxane, Opdivo, Opdualag, Yervoy
Hematology
Empliciti, Idhifa, Inrebic, Onureg, Pomalyst, Reblozyl, Revlimid, Sprycel
Boehringer-Ingelheim
Cathy Berry
Reimbursement Access Associate Director
Cell Phone: 716 481 1563
E-mail: catherine.berry@boehringer-ingelheim.com
Gilotrif: https://www.gilotrifhcp.com/starting-your-patient
Gilotrif Commercial Co-Pay
For more information on the BI Cares Foundation, call 1-855-297-5906 or visit www.boehringer-ingelheim.us/our-responsibility/patient-assistance-program
Caris Life Sciences
Amy Fleming
Account Manager
Mobile: 413-530-0069
Email: afleming@carisls.com
Patient Access Page: https://www.carislifesciences.com/patients/
Patient Financial Services: https://www.carislifesciences.com/patients/financial-services/
Katheryne Murray
Practice Experience Manager- Northeast
Cell: 860-876-5568
Rubraca® (rucaparib)
Coherus Biosciences, Inc.
Jo Ann Escanlar
Director, Field Reimbursement
469-797-9809
Charlie Flynn
Associate Director of Reimbursement for Northeast
Daiichi Sankyo
211 Mount Airy Drive
Basking Ridge, NJ 07920
Work (410) 688-4109
Email - charles.flynn@daiichisankyo.com
Products- Enhertu, Vanfltya, Injectafer, Turalio
https://dsiaccesscentral.com/hcp/vanflyta-/financial-help/copay
https://www.injectafercopay.com/hcp/login
Dova Pharmaceuticals
Richard DeBone
Director- Market Access
Dova Pharmaceuticals
rdebone@dova.com
724.953.9661
RJ Valera
Oncology Lead, Access & Reimbursement
Eisai Inc.
200 Metro Blvd
Nutley, NJ 07710
Office Tel: (201)746-2115
Lenvima and Halaven
Eisai Assistance Program
For program and eligibility information, and to review the program terms and conditions, please visit, https://www.eisaipatientsupport.com/hcp/lenvima/patient-support or call 1-866-61-EISAI (1-866-613-4724)
EMD Serono
Walter Serafin, MA, BA
Associate Director, Field Patient Services - Oncology
EMD Serono, Inc.
Mobile: (339) 214-6080
Office: (913) 322-6063
One Technology Place
For Bavencio:
CoverOne.com
Phone: (844) Cover1 or (844) 826-8371
Monday-Friday: 8:00am-8:00pm ET
For Tepmetko:
OncNavigationCenter.com
Phone: 1-844-662-3631 (844-ONC-EMD1)
Fax: 844-501-0062
Monday–Friday: 8:00 am–8:00 pm ET
Exelixis
Michele Sofarelli Luther
Patient Access Director
CABOMETYX.com
207-838-2364
msofarelli@exelixis.com
Exelixis Access Services
Cell: 475-254-6532
E-mail: Villarreal.Paul@gene.com
https://www.genentech-access.com
copayassistancenow.com
https://www.gene.com/patients/patient-foundation
855-MYCOPAY (855-692-6729)
Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab)
Oral Products: ALECENSA® (alectinib), COTELLIC® (cobimetinib), ERIVEDGE® (vismodegib),GAVRETO (pralsetinib),ROZLYTREK® (entrectinib), TARCEVA® (erlotinib), VENCLEXTA™ (venetoclax) ZELBORAF® (vemurafenib)
Subcutaneous Products: HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human)
Genmab US, Inc.
David R Taylor
Associate Director, Field Reimbursement
1-609-455-3411
Genomic Health
Dan Monteith
Regional Oncogenomic Liaison
Genomic Health
m 650.722.7043 or 866.613.3015
f 603.488.5565
dmonteith@genomichealth.com
Gilead
Melissa McLean
Field Reimbursement Senior Manager (Northeast)
M: (914) 715-7535
Email: melissa.mclean1@gilead.com
Zydelig (idelalisib)
https://www.zydeligaccessconnect.com/patient
1-844-622-2377
Yescarta (axicabtagene ciloleucel)
https://www.yescarta.com/support#kite-konnect
1-844-454-5483
Trodelvy/Gilead
Access Services: https://www.gileadoncologysupport.com/
GlaxoSmithKline
Michael Savoia
Northeast Oncology FRM
Managed Markets & Government Affairs
5 Moore Drive, PO Box 13398, RTP, NC 27709-3398
United States
Email michael.j.savoia@gsk.com
Cell 914-588-3473
www.togetherwithgskoncology.com
GT Medical Technologies, Inc.
Reimbursement Support
1.833.662.0044
Julie Garfield
Dakota Fog
dfog@gtmedtech.comGuardant Health
Joana Buxhaku
Mobile +1-781-219-8511
Client Services 855-698-8887
Patient Program: Guardant Access Program https://guardanthealth.com/precision-oncology/for-patients/
Genomic tests included in the Guardant Access Program:
Guardant360 CDx
Guardant360
Guardant360 TissueNext + PDL1
Guardant360 Response
Guardant Reveal
Heron Therapeutics
Michelle Wollersheim
Director, National Accounts /Reimbursement
C: 414-687-5624
E: mwollersheim@herontx.com
CINVANTI® (aprepitant) injectable emulsion
SUSTOL® (granisetron) extended-release injection
Incyte
Marcy Gingerich
Field Access Manager, McKesson
740-405-2240
Marcy.Gingerich@McKesson.com
Jakafi (ruxolitinib)
Pemazyre (pemigatinib)
Zynyz (retifanlimab-dlwr)
855-452-5234
Monjuvi (tafasitamab-cxix)
855-421-6172
Primary Contact:
Erika Ziegler
Sales regional manage
erika.ziegler@ipsen.com
Melissa Kramer
Regional Reimbursement Director
978-701-8568
Email:melissa.kramer@ipsen.com
Somatuline Depot(Lanreotide), and Onivyde(Irinotecan Liposome Injection) and Tazverik (tazmetostat)
Patient Access services: www.ipsencares.com
Janssen
Ward Bennett
Healthcare Policy and Advocacy Director
Strategic Customer Group
Johnson & Johnson
Health Care Systems Inc.
8 Bloody Brook Rd
Amherst NH 03031 USA
T: 603-672-9381
M: 603-345-1404
wbennett@its.jnj.com
http://www.janssencarepath.com/
DARZALEX® (daratumumab), YONDELIS® (trabectedin), ZYTIGA® (abiraterone acetate), DOXIL® (doxorubicin HCl liposome injection), PROCRIT® (epoetin alfa), and SYLVANT® (siltuximab),ERLEADA® (apalutamide).
Janssen CompassTM support program dedicated to patients who have been prescribed either ERLEADA® (apalutamide), DARZALEX® (daratumumab), or DARZALEX Faspro® (daratumumab and hyaluronidase-fihj) https://www.janssencompass.com
Jazz Pharmaceuticals
Lynn Monte
Access & Reimbursement Manager
Hematology/Oncology
Jazz Pharmaceuticals
3170 Porter Drive
Palo Alto, CA 94304
508-873-1445
Lynn.monte@jazzpharma.com
www.jazzcares.com
Jacqueline Buckley
Corporate Account Director
85 Wells Avenue Suite 210
Newton MA 02459
Cell: 774- 236-0231
jbuckley@karyopharm.com
XPOVIO® (selinexor)
For HCPs: www.XPOVIOpro.com
https://www.karyforward.com
Steven McRae
Market Access Leader, Northeast Region
Cell: (908) 812-8938
steven.mcrae@lantheus.com
PYLARIFY Reimbursement Support: https://www.pylarify.com/ordering-and-reimbursement
PYLARIFY Support Hotline telephone number 1-844-339-8514
Lilly USA
Mary E. Mergy, MBA
Oncology Field Reimbursement Manager – Northeast
Eli Lilly and Company
314.601.7421 (mobile)
mergy_mary@lilly.com
https://www.lillyoncologysupport.com
Cyramza (ramucirumab), Alimta (pemetrexed), Erbitux (cetuximab),Retevmo (Selpercatinib), Verzenio (abemaciclib), Portrazza (necitumumab)
Verzenio Continuous Care Program
Verzenio.com
1-844-verzenio (1-844-837-9364)
Lilly Cares Foundation
Lillycares.com
1-800-545-6962
Michael Keyes
Field Reimbursement Manager
Mobile: (814) 823-3097
Email: michael.keyes@merck.com
Mark Montello
Medicare Account Executive
Mark.Montello@merck.com
603-321-1145
Elizabeth Gugliotta
Associate Director Access & Reimbursement
Elizabeth.Gugliotta@novartis.com
Cell: 401-480-9905
Ph+ CML-CP | SCEMBLIX® (asciminib) Tablets | HCP
HR+/HER2- eBC & mBC Treatment | KISQALI® (ribociclib) | HCP
Oncopeptides
Kelly Draveling
National Account Executive
kelly.draveling@oncopeptides.com
816-522-2032
PEPAXTO (melphalan flufenamide)
Field Access Specialist – Northeast
Cell: 603-777-6362
Email: Jason.hart@abbvie.com
IMBRUVICA (ibrutinib) Patient Access & Support Services: www.imbruvicabyyourside.com
Pfizer
Julie Rogers, MBA, CRT, CPC
Field Reimbursement Manager
Pfizer Oncology
860-422-0420
Julie.rogers@pfizer.com
Pfizer Patient Assistance:
Besponsa, Bosulif, Braftovi, Daurismo, Ibrance, Inlyta, Lorbrena, Mektovi, Mylotarg, Talzenna, Vizimpro, Xalkori
Reimbursement Support and Co-pay assistance only: Elrexfio, Nivestym, Nyvepria, Ruxience, Trazimera, Zirabev
Puma Biotechnology
Laurie Rosa, BSN RN OCN CBCN
603-401-0739
LRosa@pumabiotechnology.com
NERLYNX® (neratinib)
Regeneron
Jeanne Leahy
Phone: 215-285-0068
Email: Jeanne.leahy@sanofi.com
Libtayo: Libtayo Surround
Rigel Pharmaceuticals
Kent Main
Senior Territory Business Manager
Me/NH/VT North Shore Mass.
207-841-5156 cell
kmain@rigel.com
Sandoz Biopharmaceuticals
Andrew Palsha
Reimbursement Policy Manager
508 735-1941
andrew.palsha@sandoz.com
https://www.sandozonesource.com/
Sanofi
Chris Ramsay
Key Account Manager: Northeast
Phone: 617-529-3998
Christopher.Ramsay@sanofi.com
Drug Names:
Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase)
Drug Names:
Cerezyme - imiglucerase
Cerdelga - eliglustat
https://www.careconnectpss.com/
Drug Names:
Rezurock-Belumosudil)
Seagen
Michelle L. Vallee
Senior Oncology Account Manager
(207)229-6702
855.4SECURE (855.473.2873), Option 1
ADCETRIS® (brentuximab vedotin)
PADCEV™ (enfortumab vedotin-ejfv) (See Astellas)
TUKYSA®(tucatinib)
Tivdak™ (tisotumab vedotin-tftv)
Secura Bio
Gynt Padegs
Cell: 716 998 9860
Copiktra (duvelisib)
https://securabio.com/patient-support-programs
Secura Care: 844-9SECURA (844-973-2872)
Servier
Wendy Poage
Patient Advocacy
Oncaspar, Asparlas, Tibsovo
Wendy.Poage@servier.com
617-335-7987
Tina Belcastro
Reimbursement Contact
tina.belcastro@servier.com
603-770-0647
For help with access and financial assistance, call 800-813-5905 or visit ServierOne.com.
ServierONE
Email; USPatientServices@servier.com;
1-844-409-1141 (Tibsovo)
1-800-813-5905 (All other Products)
Tibsovo (Ivosidenib)
Voranigo (Vorasidenib)
Asparlas (Calasparagase pegol-mknl)
Oncaspar (Pegaspargase)
Sobi
Kara Olenio – Health System Director
Kara.Olenio@sobi.com
603-843-7336
Gamifant® (emapalumab-lzsg)
For Caregivers & Patients (gamifantcares.com)
Amanda Erickson
Territory Business Manager
Cell: 603-770-4039
Email: Amanda.Erickson@springworkstx.com
Our Product: Ogsiveo/nirogacestat
Patient Support Services: SpringWorks CareConnections™ Patient Support Program
Stemline, a Menarini Group Company
Angela Johnson
Field Reimbursement Director, Northeast
Cell: 724-858-6285
ajohnson@menarinistemline.com
Products: ORSERDU/ELZONRIS
Website: https://stemline.com/
Our product website are:
ORSERDU: https://www.orserdu.com/
ELZONRIS: https://www.elzonris.com/
Patient assistance website: https://stemlinearc.com/
Angela Johnson
Field Reimbursement Manager, Northeast
Cell: 724-858-6285
ajohnson@stemline.com
ELZONRIS
www.elzonris.com
Stemline ARC Patient Assistance
Bob Stewart
Director, Market Access
Taiho Oncology, Inc.
101 Carnegie Center, Suite 101
Princeton, NJ 08540
609 575-5169
rstewart@taihooncology.com https://www.taihooncologycopay.com/
Takeda
Deborah Looney
Field Access Director
Ph: 617-543-9736
deborah.looney@takeda.com
Takeda Oncology Here2Assist™
Teva Pharmaceutical Industries Ltd.
Kate Friday
Director Patient Services
Kate.Friday@tevapharm.com
973-214-8394
US ACT Parsippany, NJ
TG Therapeutics
Kelly Bucklen
401.261.5262
Ukoniq (Umbralisib)
Acredo Specialty Pharmacy Jeremy Boehm
Sr. Account Director
Accredo Specialty Pharmacy
M: 781-980-2179
F: 855-817-2712
jboehm@express-scripts.com
Diplomat Specialty Pharmacy
Yakini Brown
Pharmacy Liaison
P. 810.768.9115
F. 810.262.0261
ybrown@diplomat.is
Foundation Medicine
Bill Walsh
Senior Account Executive | New England
C: 603.391.8174
Client Services: 888.988.3639
Foundation Medicine, Inc.
150 Second Street, Cambridge, MA 02141
bwalsh@foundationmedicine.comKroger Specialty Pharmacy
Kevin B. Penner
Oncology Specialty Account Manager- New England
Phone: 860-227-3458
Fax: 888-315-3270
kevin.penner@krogerhealth.com
www.krogerspecialtypharmacy.com
Last updated 11/19/24 - ES